| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/26/1999 | DE19835633C1 Animal or human tumor cells which express immunoglobulins |
| 08/26/1999 | CA2687533A1 Immunological methods to modulate myostatin in vertebrate subjects |
| 08/26/1999 | CA2337638A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 08/26/1999 | CA2322617A1 Compounds and methods for diagnosis of tuberculosis |
| 08/26/1999 | CA2321973A1 Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| 08/26/1999 | CA2321224A1 Phosphodiesterase 10 |
| 08/26/1999 | CA2321222A1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses |
| 08/26/1999 | CA2321186A1 Apoptosis inducing molecule ii and methods of use |
| 08/26/1999 | CA2321165A1 Antibodies against human cd40 |
| 08/26/1999 | CA2321140A1 Inhibitors of complement activation |
| 08/26/1999 | CA2321106A1 Group b streptococcus antigens |
| 08/26/1999 | CA2321101A1 Modified heat shock protein-antigenic peptide complex |
| 08/26/1999 | CA2320808A1 Compositions and methods for sensitizing and inhibiting growth of human tumor cells |
| 08/26/1999 | CA2320632A1 Caf1-related protein |
| 08/26/1999 | CA2320060A1 Skin care compositions |
| 08/26/1999 | CA2319038A1 Analgesic peptides from venom of grammostola spatulata and use thereof |
| 08/25/1999 | EP0937982A2 Diagnostic and therapeutic agent for treatment of autoimmune hepatitis |
| 08/25/1999 | EP0937777A2 GABA receptors and their uses |
| 08/25/1999 | EP0937463A1 Skin care compositions |
| 08/25/1999 | EP0937462A1 Vaccine compositions for mucosal delivery |
| 08/25/1999 | EP0937251A1 Purification of antigen-specific t cells |
| 08/25/1999 | EP0937153A1 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen |
| 08/25/1999 | EP0937148A1 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability |
| 08/25/1999 | EP0937146A2 Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin |
| 08/25/1999 | EP0937143A2 Secreted proteins and polynucleotides encoding them |
| 08/25/1999 | EP0937140A2 Recognition molecules interacting specifically with the active site or cleft of a target molecule |
| 08/25/1999 | EP0937105A1 Vaccine against carbohydrate antigens |
| 08/25/1999 | EP0937102A1 Human monocyte chemotactic proprotein |
| 08/25/1999 | EP0937099A1 Oligomers which inhibit the expression of interleukin genes |
| 08/25/1999 | EP0936923A1 SUPPRESSION OF TNF $g(a) AND IL-12 IN THERAPY |
| 08/25/1999 | EP0936922A1 Polynucleotide vaccine formula for treating horse diseases |
| 08/25/1999 | EP0936921A1 Two-step immunization procedure against the pyramyxoviridae family of viruses using attenuated viral strains and subunit protein preparation |
| 08/25/1999 | EP0936920A1 NON-IgA Fc BINDING FORMS OF THE GROUP B STREPTOCOCCAL BETA ANTIGENS |
| 08/25/1999 | EP0646016B1 Synthetic peptides for the treatment of myasthenia gravis |
| 08/25/1999 | CN1226927A Preparation of ionically cross-linked polyphosphazene microspheres by coacervation |
| 08/25/1999 | CN1226897A Isolated peptides derived from mage-2 |
| 08/25/1999 | CN1226896A Modulating activity of hormones or their receptors-peptides, antibodies, vaccines and uses thereof |
| 08/25/1999 | CN1226842A Preservation by foam formation |
| 08/25/1999 | CN1226830A Egg anti-inflammatory composition, method of isolation and use |
| 08/25/1999 | CN1226829A Method for treating gastrointestinal damage |
| 08/24/1999 | US5942419 RsbW-1 encoding nucleic acids |
| 08/24/1999 | US5942416 Treatment of infections from bacteria using polypeptides and polynucleotides |
| 08/24/1999 | US5942413 Polynucleotide fragment that codes an antigen from parasitic worms; antihelmintics |
| 08/24/1999 | US5942405 Identifying compounds which inhibit complement receptors by mixing cells expressing surface complement receptors with a labeled compound capable of binding receptor and determining if compound inhibits interactions by signal generation |
| 08/24/1999 | US5942404 Diagnosing leukemia by incubating cells with specific antibodies and detecting surface antigens |
| 08/24/1999 | US5942403 Compounds and methods for the detection of t. cruzi infection |
| 08/24/1999 | US5942402 Method of detecting and treating cancer |
| 08/24/1999 | US5942401 An in vitro assay detecting the presence of cytotoxic t-cell response to rev and or tat proteins |
| 08/24/1999 | US5942400 Assays for detecting β-secretase |
| 08/24/1999 | US5942242 Medicaments for nasal administration |
| 08/24/1999 | US5942237 Pharmaceutical preparation for topical administration of antigens and/or vaccines to mammals via a mucosal membrane |
| 08/24/1999 | US5942236 Potential vaccine for use against lyme disease to induce a protective immune response in humans by administrating a purified immunogenic outer surface lipoprotein of micelle form |
| 08/24/1999 | US5942235 Exogenous dna encoding an antigenic determinant of a pathogen; recombinant viruses and gene products are useful for cancer therapy |
| 08/24/1999 | US5942234 Hepatitis C virus asialoglycoproteins |
| 08/24/1999 | US5942230 Composition of immunotoxins and retinoids and use thereof |
| 08/24/1999 | US5942210 Methods for lyoprotecting a macromolecule using tricine |
| 08/24/1999 | CA2248972A1 Novel compounds |
| 08/24/1999 | CA2141475C Type 1 and type p fimbriae-adhesins isolated from novel e. coli strains, process for their preparation and uses thereof |
| 08/20/1999 | CA2249653A1 Novel compounds |
| 08/19/1999 | WO1999041614A2 Method for detecting intimin producing microorganisms |
| 08/19/1999 | WO1999041610A1 Serological diagnosis of chagas' disease |
| 08/19/1999 | WO1999041404A2 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs |
| 08/19/1999 | WO1999041402A2 Targeting of genetic vaccine vectors |
| 08/19/1999 | WO1999041383A1 Antigen library immunization |
| 08/19/1999 | WO1999041376A2 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
| 08/19/1999 | WO1999041373A2 Human transport-associated molecules |
| 08/19/1999 | WO1999041369A2 Genetic vaccine vector engineering |
| 08/19/1999 | WO1999041368A2 Optimization of immunomodulatory properties of genetic vaccines |
| 08/19/1999 | WO1999041363A1 Podocalyxin like sialomucins having selectin ligand activity |
| 08/19/1999 | WO1999041360A1 Method for the development of an hiv vaccine |
| 08/19/1999 | WO1999041355A2 Hiv chemokines |
| 08/19/1999 | WO1999041286A1 DERIVATISED ANTIBODIES WITH EXPOSED CARBOHYDRATE CHAINS CAPABLE OF BINDING TO IMMOBILISED IgG |
| 08/19/1999 | WO1999041285A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands |
| 08/19/1999 | WO1999040946A2 Methods and compositions for modulating leptin activity |
| 08/19/1999 | WO1999040939A1 Method for the prevention and treatment of a type i hypersensitivity disorder |
| 08/19/1999 | WO1999040938A2 Vaccines comprising interleukin-12 and herpes simplex viral antigen |
| 08/19/1999 | WO1999040937A2 Vaccines comprising interleukin-12 and respiratory syncytial viral antigens |
| 08/19/1999 | WO1999040936A2 Pneumococcal and meningococcal vaccines formulated with interleukin-12 |
| 08/19/1999 | WO1999040935A1 Novel preventives/remedies for immunopathy |
| 08/19/1999 | WO1999040934A1 Strategically modified hepatitis b core proteins and their derivatives |
| 08/19/1999 | WO1999040932A1 Mixed micellar pharmaceutical delivery system and method of preparation |
| 08/19/1999 | WO1999040925A2 Hapten-modified tumor cell membranes and their use |
| 08/19/1999 | WO1999040881A2 Specific antibodies against mammary tumor-associated mucin, method for production and use |
| 08/19/1999 | WO1999031250A3 Constitutive expression of non-infectious hiv-like particles |
| 08/19/1999 | WO1999030670A3 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |
| 08/19/1999 | WO1999029871A3 Circovirus sequences related to piglet weight loss disease (pwd) |
| 08/19/1999 | WO1999025815A3 Nucleic acids involved in the responder phenotype and applications thereof |
| 08/19/1999 | WO1999025380A3 Methods and compositions for the treatment of psoriasis |
| 08/19/1999 | WO1999023227A3 Hyaluronan synthase gene and uses thereof |
| 08/19/1999 | WO1998050423A3 Peptide analogues, and their uses in particular in pharmaceutical compositions and for diagnosis |
| 08/19/1999 | CA2323011A1 Method for the development of an hiv vaccine |
| 08/19/1999 | CA2321277A1 Derivatised antibodies with exposed carbohydrate chains capable of binding to immobilised igg |
| 08/19/1999 | CA2321136A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands |
| 08/19/1999 | CA2320969A1 Hapten-modified tumor cell membranes, and methods of making and using hapten-modified tumor cell membranes |
| 08/19/1999 | CA2320960A1 Optimization of immunomodulatory properties of genetic vaccines |
| 08/19/1999 | CA2320958A1 Antigen library immunization |
| 08/19/1999 | CA2320753A1 Method for detecting intimin producing microorganisms |
| 08/19/1999 | CA2320626A1 Genetic vaccine vector engineering |
| 08/19/1999 | CA2320512A1 Novel preventives/remedies for immunopathy |
| 08/19/1999 | CA2320431A1 Targeting of genetic vaccine vectors |